What does it take to move drug discovery from fragmented systems to a predictive, AI-enabled future? Philip Mounteney breaks down the industry's data problem, the promise of agentic AI, and how digital threads can connect discovery, development, and manufacturing. This episode offers a grounded look at how life sciences organizations can work faster, fail earlier, and build toward more personalized medicine.
